Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine vs Conventional Chemotherapy in Elderly AML Consolidation
NCT01794169Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Mar 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Karolinska University Hospital. Started Mar 2013; status: terminated.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01794169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794169.